Abstract CT227: Interim Results of a Phase 1b/2 Study of ADG126 (a Masked Anti-Ctla-4 SAFEbody®) Monotherapy and in Combination with Toripalimab (an Anti-Pd-1 Antibody) in Patients (pts) with Advanced/metastatic Solid Tumors
Cancer Research(2023)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined